Angela Walsh

Insider Reports History

Location
Alpharetta, GA
Signature
/s/ Greg Duncan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Angela Walsh:

Company Role Class Num Shares Value Price $ Report Date Ownership
Dogwood Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 82,500 05 Mar 2026 Direct

Insider Reports Filed by Angela Walsh

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DWTX Dogwood Therapeutics, Inc. 05 Mar 2026 1 $0 4 Chief Financial Officer 06 Mar 2026, 16:18
DWTX Dogwood Therapeutics, Inc. 04 Dec 2025 1 $0 4 Chief Financial Officer 05 Dec 2025, 16:05
DWTX Dogwood Therapeutics, Inc. 27 Jun 2025 1 $0 4 Chief Financial Officer 01 Jul 2025, 13:56
DWTX Virios Therapeutics, Inc. 26 Feb 2024 1 $0 4 SVP OF FINANCE 28 Feb 2024, 12:51
DWTX Virios Therapeutics, Inc. 12 Dec 2022 1 $0 4 SVP OF FINANCE 14 Dec 2022, 17:32
DWTX Virios Therapeutics, Inc. 23 Jun 2022 1 $0 4 SVP OF FINANCE 30 Jun 2022, 13:40
DWTX Virios Therapeutics, Inc. 23 May 2022 1 +$9,150 4 SVP OF FINANCE 24 May 2022, 14:53
DWTX Virios Therapeutics, Inc. 21 Jun 2021 1 $0 4 SVP OF FINANCE 22 Jun 2021, 17:05